Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,187 | 0,236 | 22:57 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
HVIVO Aktie jetzt für 0€ handeln | |||||
Mo | hVIVO announces annual report and upcoming AGM | 1 | Investing.com | ||
Mo | hVIVO kündigt Jahresbericht und kommende Hauptversammlung an | 1 | Investing.com Deutsch | ||
Mo | hVIVO PLC - Annual Report, Notice of AGM & Directorate Change | - | RNS | ||
10.04. | EARNINGS AND TRADING: Castelnau swings to profit; hVIVO sees growth | 2 | Alliance News | ||
10.04. | hVivo reports record full-year revenue, earnings | 1 | Sharecast | ||
10.04. | hVivo's chairman Cathal Friel not seeking re-election | 2 | RTE.ie | ||
10.04. | hVIVO PLC - Exercise of Options | - | RNS | ||
10.04. | hVIVO PLC - Final results | - | RNS | ||
26.03. | hVIVO PLC - AIM Rule 17 and Schedule 2(g) Update | 1 | RNS | ||
21.03. | hVIVO PLC - Notice of Results | 2 | RNS | ||
07.03. | hVIVO PLC - Director/PDMR Shareholding | 1 | RNS | ||
27.02. | hVIVO acquires biological material storage specialist Cryostore | 2 | Sharecast | ||
27.02. | hVIVO PLC - Acquisition of Cryostore for up to £3.2m | 2 | RNS | ||
17.02. | IN BRIEF: hVIVO signs £2 million deal as aims to progress hMPV care | 3 | Alliance News | ||
17.02. | Hvivo signs £2m contract with new biopharma client | 2 | Sharecast | ||
17.02. | hVIVO PLC - £2m hMPV characterisation study contract | 1 | RNS | ||
05.02. | hVIVO reports positive results from Shionogi RSV trial | 8 | Sharecast | ||
05.02. | Shionogi's RSV antiviral shows promise in hVIVO trial | 4 | Investing.com | ||
05.02. | hVIVO PLC - Shionogi reports positive RSV trial results | 5 | RNS | ||
03.02. | hVIVO wins contract for RSV drug human trial for Inhalon Biopharma | 5 | Alliance News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PLUS THERAPEUTICS | 0,505 | -5,52 % | Plus Therapeutics Inc.: Plus Therapeutics' REYOBIQ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM) | Multiple long-term LM survivors in those patients receiving multiple doses of REYOBIQ RNA sequencing data show early tumor apoptosis and activation of innate immune responses Updated ReSPECT data... ► Artikel lesen | |
LIFEWARD | 1,315 | -8,68 % | Lifeward Ltd. Reports First Quarter 2025 Financial Results | U.S. pipeline of ReWalk opportunities continues to build with over 120 qualified leads in process Closure of AlterG sites and resulting consolidation of resources and reduced expenditures yields improved... ► Artikel lesen | |
JD HEALTH | 4,440 | -3,48 % | CCBI Lifts JD HEALTH's TP to HKD45.4; 1Q25 Rev. & GPM Beat | ||
EKSO BIONICS | 0,430 | +7,50 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Accepted into NVIDIA Connect Program | ||
IMUNON | 0,540 | -1,82 % | Imunon, Inc.: IMUNON Announces Six-Month Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Trial in COVID-19 | Company's PlaCCine® technology platform demonstrates better durability and other advantages compared to mRNA vaccines Results further validate PlaCCine as a novel vaccine platform with potential applications... ► Artikel lesen | |
ROCKWELL MEDICAL | 0,880 | -3,14 % | Rockwell Medical reiterates $65M-$70M 2025 sales guidance while pursuing new customers and product expansion | ||
AVINGER | 0,340 | -6,08 % | Avinger Inc - 8-K, Current Report | ||
VIRIDIAN THERAPEUTICS | 10,860 | -3,51 % | What 5 Analyst Ratings Have To Say About Viridian Therapeutics | ||
SINTX TECHNOLOGIES | 3,255 | -8,31 % | SINTX Technologies, Inc.: SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization | Salt Lake City, UT, May 15, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT), an advanced ceramics company pioneering medical and antipathogenic applications of silicon nitride (Si3N4)... ► Artikel lesen | |
AETHLON MEDICAL | 0,430 | -100,00 % | AETHLON MEDICAL INC - 8-K, Current Report | ||
NEURONETICS | 3,710 | -3,51 % | Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month | ||
STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | Stagezero Life Sciences Ltd (2): Stagezero, ElevationMD use Aristotle to detect cancer | ||
ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
SAVARIA | 12,500 | 0,00 % | Dividendenbekanntmachungen (09.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAK AB SE0011337708 5 SEK 0,4573 EUR ADDLIFE AB SE0014401378 0,75 SEK 0,0686 EUR ALLIANZ SE DE0008404005 - 15,4 EUR ALZCHEM GROUP... ► Artikel lesen | |
IMAC HOLDINGS | 0,192 | -4,00 % | Pre-market Movers: IMAC Holdings, Planet Image International, SAB Biotherapeutics, MicroCloud Hologram, Avalon Holdings | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.30 A.M. ET).In the Green IMAC Holdings, Inc. (BACK) is up over 91% at $1.59.
Planet... ► Artikel lesen |